Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

BetterRX Offers a Better ePrescribe Solution for Hospices in States Implementing EPCS Mandates in 2021


e-prescribe mandates

States Imposing ePrescribe Mandates in 2021

“We built our ePrescribing technology to help patients to be comfortable by streamlining the medication ordering process and eliminating disruptive activities like phone calls, faxes, and rejections.” -Jared Stong, Founder/CEO BetterRX

Why Are States Implementing EPCS Mandates?

Electronic prescribing reduces opportunities for prescription fraud and opioid abuse. It also helps prescribers easily keep track of medication use while improving outcomes and increasing the speed with which controlled substances are delivered to patients. Electronic prescribing is especially important for hospice, where patients in the home setting typically require more controlled substances to manage pain and other symptoms. In these cases, caregivers other than the hospice staff are typically relied on to both obtain prescriptions from the pharmacy and help administer them.

What the EPCS Mandates Mean

Traditionally, controlled substances require a “wet” signature that includes the original prescription sent directly to the pharmacy. In the case of hospice, these “wet” prescriptions can be faxed to the pharmacy in most states, with the original sent up to 7 days later. Once the EPCS mandates go into effect, pharmacies will stop accepting “wet” signatures for controlled substances. Pharmacies that continue to accept these prescriptions for controlled substances from non-compliant electronic solutions can face fines.

Why Generic ePrescribe Solutions Don’t Work Well for Hospice

Most ePrescribe solutions used for hospice today are generic third-party solutions built for physician practices. These same generic ePrescribe solutions are often provided to hospice organizations via a third-party (usually through their PBM). Generic ePrescribe solutions frequently don’t meet the complexities of the hospice medication workflow, including formulary management and allowing the hospice care team to manage patient medications seamlessly from multiple geographic locations. When hospices use a generic third-party ePrescribe solution, it forces their clinicians and pharmacists to follow complex processes (e.g., 30+ steps), from the hospice profiling and ordering of medications to the pharmacy that fills and delivers them. Many of the 30+ steps include time-consuming phone calls, callbacks, waiting on hold, and voicemails. Also, third party solutions require additional integrations with electronic medical records solutions (EMRs), which create gaps in which prescriptions can be “lost” (e.g., without notification to either the prescriber or the pharmacy), leaving patients waiting for their much-needed medications.    

Why BetterRX’s Hospice-Specific ePrescribe is Better

BetterRX recognizes that hospice patients need to get their medications quickly to manage symptom relief. To do this, BetterRX built an ePrescribe solution that enables the hospice care team to order medications with half the steps in half the time. Today, BetterRX is the only ePrescribe solution built specifically for the hospice workflow, approved by the DEA, and certified by Surescripts.

The BetterRX ePrescribe solution is part of the BetterRX App, which uses artificial intelligence to guide the hospice care team to order the most cost-effective medications with the same therapeutic benefits. The BetterRX App creates connectivity between the hospice, their EMR, and their pharmacy so that prescriptions don’t get lost in the gaps, resulting in a smoother, faster process for ordering and receiving medications. BetterRX ePrescribe enables physicians to care for their hospice patients from anywhere, allowing them to review and sign prescriptions digitally wherever they may be. The solution also captures the digital prescriber’s signature for pharmacies and facilities simultaneously, eliminating the need to fax separate signed orders.

“We built our ePrescribing technology to help patients to be comfortable by streamlining the medication ordering process and eliminating disruptive activities like phone calls, faxes, and rejections.”

-Jared Stong, Founder/CEO BetterRX

Benefits for Pharmacies Serving Hospice

“We are a pharmacy filling for hospice, and BetterRX not only helps us ensure EPCS compliance, but BetterRX ePrescribe has completely streamlined the medication workflow with our hospices that use them. We appreciate it when a prescription shows up in our inbox from BetterRX because all of the information we need is included. We don’t have to place additional phone calls or ask questions regarding delivery schedules or medication coverage. Also, because their ePrescribe sends orders electronically, our pharmacists don’t have to stop what they’re doing to take phone orders. This has allowed our pharmacists to accomplish other tasks throughout the day.”

-Kevin C., RX Innovations

About BetterRX

BetterRX is a technology-driven hospice PBM (Pharmacy Benefit Manager) that uses its propriety artificial intelligence and hospice ePrescribing technology to dramatically improve patient comfort. BetterRX’s artificial intelligence engine provides over 244,000 evidence-based clinical recommendations for ordering, clinical effectiveness, and lower-cost alternatives. For more information, visit http://www.BetterRX.com.

Share article on social media or email:

“Critical Moves for FFL’s to Successfully Optimize Firing Range and Retail Operations”


News Image

The event included a special keynote presentation: “The Important Role FFLs Play in Protecting Themselves and Their Communities” from Thomas L. Chittum III – Assistant Director of Field Operations – Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF)

Topics also presented include:

  • “Being Prepared” Means Much More than Just Completing a Checklist – It Requires Time-Sensitive Updates, Professional Support, and Access to Intelligent Guidance for Critical Long-Term Survival”


Presented by FFL Consultants

  • “Firing Range Construction, Expansion and Design-Build Considerations”


Presented by James Barthel – CEO – MT2 Firing Range Services

  • “Insurance Questions & Risk Mgmt. FFL’s Need to Know and Have In Place During Challenging Times”


Presented by Jeff Hewitt – SVP, Lockton Affinity

  • “Hot Topics Firearms Industry Employers Need to Know About During Times of Crisis”


Presented by Wendy Christie – Owner -Employer ESource

  • “Critical Gun Range Lead Waste Management Requirements”


Presented by Rob Anderson – VP- MT2 Firing Range Services

  • “Open Dialogue Discussing the Effects of the Biden/Harris Administration on the Firearms Industry”


Presented by Joseph Kavan – Partner, Kutak Rock

Those interested in viewing the replay can visit: http://www.MT2.com or http://www.FFLConsultants.com

About MT2 Firing Range Services:

MT2 specializes in providing environmental gun range cleaning and firing range services, and lead remediation for all your indoor and outdoor firing range service needs including:

  • Lead cleaning services,
  • Lead reclamation & Brass recycle
  • Range Maintenance, HVAC systems support
  • Consulting and Assessment by our OSHA/EPA experts!
  • Range Construction and Renovation
  • Lead Remediation & Abatement


We operate from regional offices across the country and always pay the highest value for range lead guaranteed!

Learn More: https://www.MT2.com

About FFL Consultants:

FFL Consultants is a specialty consultant group focusing exclusively on supporting firearms retailers, range operators, manufacturers, distributors, and importers. Our experts possess many decades of experience with ATF/OSHA regulatory compliance and the big-box sporting goods retail sector. Over the last 7 years FFL Consultants has grown from presenting at various firearms industry training and educational events sponsored by the National Shooting Sports Foundation, the ATF and FBI/NICS, to providing time-sensitive support to more than 10,000 FFLs nationwide. When it comes to supporting our FFL community, no question is too trivial and no project too difficult.

We’ve “been there done that” many times over and stand ready to help you with your everyday needs as well as your next challenge!

We stand ready to support you and your FFL business 24/7!

Learn More: https://www.FFLConsultants.com

Share article on social media or email:

Taliaz Announces CE Certification for Its PREDICTIX Digital AI Mental Health Solution


News Image

PREDICTIX Digital’s patient report empowers psychiatrists and GPs mental health prescribing decisions and management.

Receiving CE certification for PREDICTIX Digital is an important milestone for Taliaz, and a major step forward in our continued expansion of our pioneering PREDICTIX technology into Europe and other new markets

Taliaz, a mental health startup harnessing artificial intelligence (AI) to revolutionise mental health treatment and management, today announced it has completed CE Certification for its second product, PREDICTIX Digital. The registration of its digital decision-support and management solution will provide European health care and telehealth providers, psychiatrists and General Practitioners (GPs) with instant digital prescribing recommendations to rapidly optimize mental health treatment and management, while lowering costs.

Today, there is a growing economic burden on the European health system associated with diagnosing and treating mental health disorders, which has accelerated during the COVID-19 pandemic. More than 84 million people alone are estimated to suffer from mental health disorders in Europe.

With a high burden on health systems, there is a growing demand for specialist psychiatrists, yet growing waiting times to access care. This means the majority of workload falls on non-specialist Primary Care Physicians (PCPs). Currently, 80% of antidepressants are prescribed by a PCP with limited tools for treatment selection success and limited time to spend with patients. This often results in a long and painful trial and error process for patients.

PREDICTIX Digital harnesses AI to empower every doctor, whether a specialist psychiatrist or GP with instant prescribing recommendations during a patient’s face-to-face or virtual visit, in as fast as 5 minutes. While improving doctor’s efficiency and quality of care, PREDICTIX Digital can also be easily scaled and deployed as part of any telehealth solution to expand reach and lower costs of mental health care throughout Europe.

Starting in the field of depression, PREDICTIX Digital uses AI to analyse patient’s complex clinical and demographic data. It then translates these thousands of data combinations into an easy-to-use patient recommendation report that ranks antidepressants by their predicted efficacy and anticipated side effects.

Together with Taliaz’s CE-registered product, PREDICTIX Genetics, that also integrates a genetic analysis for precision prescribing, this CE certification paves the way for European launch of Taliaz’s comprehensive PREDICTIX technology. PREDICTIX can improve today’s prescribing accuracy by 47%* compared to today’s standard of care.

“Receiving CE certification for PREDICTIX Digital is an important milestone for Taliaz, and a major step forward in our continued expansion of our pioneering PREDICTIX technology into Europe and other new markets,” said Dekel Taliaz, CEO and co-founder of Taliaz. “European psychiatrists and GPs are struggling to keep up with the growing mental health burden driven by COVID-19. PREDICTIX Digital provides the first completely AI-driven digital solution to personalize mental health treatment and management that can help significantly reduce this economic burden. We look forward to working with European partners to provide this critical missing link and help patients get the right treatment the first time.”

This announcement follows Taliaz’s recent $2.7 Million EU Horizon funding award, as well as its new partnership agreement with molecular diagnostics leader, Genetic Technologies, for the distribution of its PREDICTIX products in Australia, New Zealand and the USA, pending regulatory approval.

Taliaz is currently in the process of raising an additional round of investment to further accelerate and expand commercial efforts with mental health providers, healthcare systems, and both private and public payers globally.

*Based on a retrospective analysis of STAR*D study medications versus current clinician treatment selection prescribing accuracy (Chekroud et al., 2016). STAR*D is one of the world’s largest prospective studies for optimal antidepressant administration.

About Taliaz

Taliaz is revolutionizing the treatment and management of mental health disorders with PREDICTIX. PREDICTIX is a family of CE-registered products that provide an advanced decision support software for psychiatrists and general practitioners. Harnessing artificial intelligence, PREDICTIX can enable easy, effective and rapid patient assessment, improved prescribing precision and management for a wide range of mental health conditions. Starting in the field of depression, the PREDICTIX Genetics and PREDICTIX Digital products can improve today’s prescribing accuracy by up to 47%*.

For more information, please visit predictix.ai.

Share article on social media or email:

Foot & Ankle Specialists of the Mid-Atlantic Enhances continuum of Care with Addition of EPAT, an Innovative, Non-invasive Approach to Treating Musculoskeletal Pain


News Image

“EPAT has proven to be a very effective non-invasive option for treating all kinds of injuries — especially heel pain. One of the great things about it is the ability to get patients back to activities without pain.” – Dr. David Levine, DPM

Dr. David Levine, DPM of Foot and Ankle Specialists of the Mid-Atlantic announced today the addition of Extracorporeal Pulse Activation Technology (EPAT), an evidence-based, extremely effective, non-surgical approach to treating their patients’ acute and chronic musculoskeletal pain.

Foot & Ankle Specialists of the Mid-Atlantic specializes in foot and ankle care. Their three podiatrists combined have been serving Frederick, MD for 43 years.

EPAT is the most advanced, highly effective, non-invasive treatment method cleared by the FDA for foot and ankle treatment. This proprietary technology is based on a unique set of pressure waves that stimulate the metabolism, enhance blood circulation, and accelerate the healing process.

“EPAT has proven to be a very effective non-invasive option for treating all kinds of injuries — especially heel pain. One of the great things about it is the ability to get patients back to activities without pain.,” noted Dr. David Levine, DPM.

EPAT is clinically proven and ideal for treating acute or chronic musculoskeletal pain and/or pain that significantly impairs mobility or quality of life including pain located in the foot, heel, Achilles, tendon, neuromas, and trigger points. The procedure eliminates pain and restores mobility, thus improving the patient’s quality of life.

Treatment sessions vary depending on the area being treated. Generally, 3-5 treatment sessions, 5-10 minutes each, at weekly intervals are required.

“EPAT has a proven success rate that is equal to or greater than that of traditional treatment methods, including surgery, and without the risks, complications, and lengthy recovery time,” stated Gregory R. Mercure, President & CEO of CuraMedix, the leading U.S distributor of STORZ Medical EPAT devices.

Some patients report immediate pain relief after the first treatment, although it can take up to four weeks for pain relief to begin. Over 80% of patients treated report to be pain free and/or have significant pain reduction.

The benefits of EPAT include:

●    Evidence-based success

●    Faster, easier healing

●    Non-invasive

●    No anesthesia required

●    No scarring

●    No downtime

●    Over 80% patient satisfaction

Patients can:

●    Receive treatment in the office or even on site.

●    Bear weight (i.e. walk) immediately

●    Return to work/normal activities

●    Resume strenuous activities after 4 weeks

With EPAT, patients are in a position to feel better faster and can often avoid surgery. To learn more about EPAT and whether you are a good candidate for this treatment, please contact Foot & Ankle Specialists of the Mid-Atlantic at footandankle-usa.com.

About Foot & Ankle Specialists of the Mid-Atlantic (FASMA)

All FASMA offices treat diabetic feet, wounds, heel/arch pain, tendonitis and more…..we treat patients of all ages. To make an appointment with FASMA and learn more about EPAT, call 301-696-0818 or visit footandankle-usa.com.

About CuraMedix:

CuraMedix is an emerging leader in medical technology focused on regenerative medicine and non-invasive healing solutions, including Extracorporeal Pulse Activation Technology (EPAT®), in the treatment of acute and chronic musculoskeletal pain. CuraMedix is the leading U.S. distributor of Storz Medical’s EPAT devices. For more information on the technology or products, visit http://www.curamedix.com.

Share article on social media or email:

MaintenX International Celebrates National Handwashing Awareness Week


A pair of washing hands are covered in soap bubbles, ready to be put under a running faucet in a white sink basin.

MaintenX International highlights the import impact handwashing can have on public health during National Handwashing Week.

This year more than ever, the 20 seconds you spend washing your hands can literally save lives – and it’s all thanks to plumbing

COVID-19 has turned previously innocuous activities into a serious matter of health. From shaking a new acquaintance’s hand to planning indoor gatherings, any actions involving interpersonal interaction have taken on a new importance. At the top of that list is something that everyone does every day – handwashing. Practicing this basic act of hygiene correctly can have a huge impact on public health, which is what National Handwashing Awareness Week highlights. MaintenX International provides top-of-the-line plumbing services to commercial facilities around the country, facilitating handwashing coast-to-coast.

“We are proud to install and maintain the infrastructure that supports sound public health practices,” said MaintenX VP of Development Bill Schaphorst. “This year more than ever, the 20 seconds you spend washing your hands can literally save lives – and it’s all thanks to plumbing.”

CDC guidelines recommend washing your hands for 20 seconds with soap and warm water. Since the pandemic, 90% of Americans report handwashing more frequently, longer, or more thoroughly. COVID has also sparked a surge in installations of touchless bathroom fixtures, as another way to avoid spreading the virus.

MaintenX has been installing and maintaining every kind of commercial plumbing infrastructure for more than 40 years. To learn more about them and the services they provide, visit http://www.maintenx.com or call 855-751-0075.

ABOUT MAINTENX INTERNATIONAL:

MaintenX International is a fully licensed facilities repair company. They are one of the largest national self-performing facility maintenance and repair companies in the U.S. MaintenX has created a network of knowledgeable and professional technicians throughout the country. With their team of well-trained technicians, MaintenX self-performs and manages facility maintenance for clients. In the event there is not a MaintenX technician in the area, the company has fostered a network of preferred vendor partners throughout the country to provide superior service for their clients. For more than 40 years, MaintenX has been expertly serving multi-location retail stores, restaurant chains, and Fortune 500 companies nationwide.

Share article on social media or email:

Joe DiMaggio Children’s Hospital Earns 2020 Leapfrog ‘Top Hospital Award’ for Outstanding Quality and Safety


The surgical nurses at Joe DiMaggio Children’s Hospital (Hollywood, FL) show love is in their hands and hearts.

“We hold our standards high because that is what children and families deserve and what we would expect for our own families.”

Underscoring its nationally recognized achievements in patient safety and quality, Joe DiMaggio Children’s Hospital was the only South Florida pediatric hospital named as a Top Children’s Hospital nationally by The Leapfrog Group. Announced November 8, the Leapfrog Top Hospital award is widely acknowledged as one of the most competitive awards American hospitals can receive.

The Top Hospital designation is bestowed by The Leapfrog Group, a national watchdog organization of employers and other purchasers widely acknowledged as the toughest standard-setters for health care safety and quality.

“Providing the highest-quality care for our patients with love and compassion is what we strive for every single day, and we are grateful to be recognized for this honorable distinction,” said Caitlin Stella, Chief Executive Officer, Joe DiMaggio Children’s Hospital. “We hold our standards high because that is what children and families deserve and what we would expect for our own families.”

Over 2,200 hospitals were considered for the award and only 105 were selected as Top Hospitals, including Joe DiMaggio Children’s Hospital. The quality of patient care across many areas of hospital performance is considered in establishing the qualifications for the award, including infection rates, practices for safer surgery, maternity care, and the hospital’s capacity to prevent medication errors. The rigorous standards are defined in each year’s Top Hospital Methodology.

“Being recognized as a Top Hospital is an extraordinary feat and we are honored to recognize Joe DiMaggio Children’s Hospital this year,” said Leah Binder, president and CEO, The Leapfrog Group. “Despite the extraordinary pressure and strain of the COVID-19 pandemic, Joe DiMaggio Children’s Hospital has demonstrated an unwavering dedication to patients and to the Hollywood community. We congratulate the board, staff and clinicians whose efforts made this honor possible.”

To qualify for the Top Hospitals distinction, hospitals must rank top among peers on the Leapfrog Hospital Survey, which assesses hospital performance on the highest standards for quality and patient safety, and achieve top performance in its category. To see the full list of institutions honored as 2020 Top Hospitals, visit leapfroggroup.org/tophospitals.

Joe DiMaggio Children’s Hospital is one of South Florida’s leading pediatric hospitals, offering a comprehensive scope of healthcare services and programs in a caring, compassionate setting designed specifically for children. Part of the Memorial Healthcare System, the level one pediatric trauma center combines advanced technology, the expertise of some of the region’s most diverse, board-certified specialists, and a patient and family-centered focus to heal the body, mind, and spirit of those it touches.

To learn more, visit http://www.jdch.com and connect with @jdchospital on Facebook, Twitter, YouTube and Instagram.

Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps forward in the quality and safety of American health care. The flagship Leapfrog Hospital Survey collects and transparently reports hospital performance, empowering purchasers to find the highest-value care and giving consumers the lifesaving information, they need to make informed decisions. The Leapfrog Hospital Safety Grade, Leapfrog’s other main initiative, assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents and infections.

Share article on social media or email:

PathAI Present Machine Learning Models that Predict the Homologous Recombination Deficiency Status of Breast Cancer Biopsies at the 2020 SABCS


PathAI, a global provider of AI-powered technology applied to pathology research, today announced the result of a proof-of-concept investigation into ML model prediction of HRD directly from H&E-stained biopsy slides. DNA damage repair pathways, such as homologous recombination, have essential roles in healthy cells, and mutations in these pathways are closely associated with an increased risk for cancer, as well as cancer progression. HRD results from mutations in BRCA1/2, as well as other genes that encode the homologous recombination components that are responsible for error-free repair of double-strand breaks in DNA. HRD tumors are sensitive to poly-ADP ribose polymerase (PARP) inhibitors and platinum-based chemotherapy, making determination of a patient’s tumor HRD status clinically important. Genomic sequencing is currently the gold standard to classify a tumor as HRD or homologous recombination proficient, but this method has a high error rate, leaving a great unmet need to develop robust and reliable HRD scoring tools.

“Identifying the underlying molecular drivers of cancer has tremendous significance not only for our fundamental understanding of the disease biology, but because these image-based assays may also play an important role in making patient treatment decisions in the future, like choosing the most effective therapeutic,” said PathAI co-founder and Chief Executive Officer Andy Beck MD, PhD. “Our ability to find these signatures in widely available H&E images suggests that our models could have a great impact, and we look forward to investigating this further and validating these results in future studies.”

PathAI used two different approaches to predict the HRD status of a tumor from the H&E-stained tissue biopsy. Models were trained using breast cancer tumor biopsy images from TCGA and HRD scores of these same biopsies generated by Knijnenburg and colleagues (published in Cell Reports. 2018. 23:239-254). The Human Interpretable Features (HIF)-based model was trained using thousands of expert pathologist annotations of cell- and tissue-level features of the TCGA images to predict HRD status from HIF-based correlations, whereas the end-to-end model learned to predict HRD status directly from the biopsy image.

Both models predicted HRD with high accuracy, with the HIF-based model having an AUROC of 0.87, and the end-to-end model a AUROC of 0.80. The HIF-based model also revealed that HRD tumors have greater degree of necrosis and also more lymphocytes within the tumor itself than homologous recombination proficient tumors. These results show the enormous potential for digital pathology to identify clinically-significant genomic phenotypes that could not be detected using traditional pathology methods. PathAI will continue to develop and validate these important models for future clinical application.

About PathAI

PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. Based in Boston, PathAI works with leading life sciences companies and researchers to advance precision medicine. To learn more, visit https://www.pathai.com.

Share article on social media or email:

Healthworx Partners LLC Prepares a Handful of Hemp Oil Treats For Their Customers


Broad Spectrum CBD Vape pens, CBN oil, CBG oil

Brand New Healthworx Partners Products

We test all of our products in independent labs, with all lab results being transparent and available on our websites.

Healthworx Partners LLC, a Colorado-based company with two established CBD brands, Vapenterps and Healthworx CBD, released three new products derived from natural Colorado-grown hemp – Broad Spectrum vape pen, CBN oil, and CBG oil.

VapeNTerps is now offering pure broad spectrum distillate CBD vape pens with CBD, CBG, CBN, CBC, and CBDV – and absolutely free of any carrying agents. This top-of-the-line formula offers an ultimate vape experience with 33 unique strains, bringing performance and safety to the next level.

Healthworx CBD formulated two additional oils to improve your CBD experience. Next to their ever-popular CBD oil offering, they introduce the new CBN oil for sleep and CBG oil as an exceptional alternative to all CBD oil fans out there. CBN oil is a superbly balanced mixture of 150mg of CBN and 450mg of CBD extract and organic coconut oil, thoroughly tested for potency and purity.

They offer another extraordinary aid to your overall wellness –CBG oil with 500mg of CBG and 500mg of CBD extract, blended in coconut oil. Satisfying even the most distinct taste, both oils come in the standard 30ml bottle, suitable for 30 servings.

“All of our products are made from naturally grown hemp and are entirely GMO-free, without any harmful compounds. We test all of our products in independent labs, with all lab results being transparent and available on our websites”, said the two founders of Healthworx Partners LLC.

They also use strict CO2 extraction methods, which often exceed all industry standards. Healthworx Partners LLC always offers safe packaging for easy consumption, which is suitable for all CBD users.

Healthworx Partners LLC is a CBD company based in Denver, Colorado. Since its founding, Healthworx Partners LLC prides itself on being a customer-oriented wellness brand. Their mission is to create organic, natural hemp products that promote and enhance healthy lifestyles. For more information on Healthworx Partners LLC, visit https://hwxcbd.com and https://vapenterps.com.

                                        ###

Share article on social media or email:

Confluent Health Announces Partnership with Mountain River Physical Therapy


Burt Reed, Mountain River Physical Therapy Owner

Our goal is to stay dedicated to our patients, and, through our partnership with Confluent Health, provide our team members with the advanced tools required to stay at the forefront of best-in-class patient care.– Burt Reed, Mountain River Physical Therapy Owner

Confluent Health is proud to announce its newest partnership with Mountain River Physical Therapy, a therapist-owned outpatient physical therapy practice with 24 clinic locations and two performance centers throughout West Virginia, Pennsylvania, Ohio, Virginia, Florida. The group operates as Kinesis Physical Therapy in Minnesota.

“Since our founding in 1999, Mountain River has been dedicated to our patients by attracting and

retaining the best clinicians in the Mid-Ohio Valley region,” says Mountain River Physical

Therapy owner Burt Reed, PT, OCS, FAAOMPT. “Our goal is to stay dedicated to our patients,

and, through our partnership with Confluent Health, provide our team members with the

advanced tools required to stay at the forefront of best-in-class patient care.”

This partnership allows for Mountain River to maintain its existing brand while gaining access to

Confluent Health’s shared management services. These services include accounting and finance,

marketing and branding, and talent acquisition for further expansion. Through Confluent Health,

Mountain River therapists will also have greater access to continuing education programs and

staff development opportunities such as Evidence in Motion, a nationally recognized physical

therapy program.

“I have known Burt a long time and have admired how he has developed a pre-eminent and

progressive private practice,” says Confluent Health President and CEO Larry Benz, PT, DPT,

OCS, MBA, MAPP. “We’re excited to partner with him and his team and look forward to

spreading the Mountain River brand to patients across the Mid-Ohio Valley Region and beyond.”

Combining Mountain River’s dedicated and positive attitude with Confluent Health’s services

and expertise will make for a strong alliance in one joined mission, to get patients back to their

lives faster and healthier.

For more information on Mountain River Physical Therapy, please visit mountainriverpt.com. To

learn more about Confluent Health, visit http://www.GoConfluent.com.

###

About Confluent Health:

Confluent Health is a Louisville, Kentucky-based private holding company focused on creating a

healthcare system that recognizes physical and occupational therapy providers as the Best First

Choice for preventing and managing musculoskeletal and movement disorders. Confluent Health

offers the following management services: evidence-based practice, patient loyalty, regulatory

assurance, marketing and branding, clinic operations, hiring and retention, strategy, accounting

and finance, and customer service to Advanced and Preferred Physical Therapy, Baton Rouge

Physical Therapy-Lake, BreakThrough Physical Therapy, Capitol Physical Therapy, Confluent

Physical Therapy, El Paso Physical Therapy Specialists, OSPT, the Evidence In Motion family of

companies, Fit For Work, Lake Center for Rehab, Rehab Therapy Works, Physical Therapy

Central, ProActive Physical Therapy Specialists, Pappas | OPT Physical

Therapy, ProRehab Physical Therapy, Redbud Physical Therapy, RET Physical Therapy

Group, SporTherapy, Texas Physical Therapy Specialists, and TOSPT. Together, these

companies share a common ownership team and are committed to developing a learning,

purpose, and coaching culture.

About Mountain River Physical Therapy

Mountain River Physical Therapy is a locally owned private physical therapy practice with

clinics throughout Florida, Ohio, Pennsylvania, Virginia and West Virginia. Mountain River

Physical Therapy operates as Kinesis Physical Therapy in Minnesota. Our clinicians are

dedicated to providing and supporting personalized orthopedic, sports and industrial

rehabilitation services through manual therapy techniques.

Share article on social media or email:

Human Animal Bond Research Institute Announces New Research Showing Cats Help Children with Autism


“Our study found that children with ASD experienced significant increases in the social skill of empathy, significant decreases in problem behaviors including bullying and hyperactivity/inattention, and also less separation anxiety after the introduction of a shelter cat.”

The Human Animal Bond Research Institute (HABRI) today announced the results of a new study published in the Journal of Pediatric Nursing titled, “Exploratory study of cat adoption in families of children with autism: Impact on children’s social skills and anxiety,” demonstrating that children with autism spectrum disorder (ASD) may experience increases in empathy and decreases in problem behaviors after adoption of a shelter cat into their families.

“Our study found that children with ASD experienced significant increases in the social skill of empathy, significant decreases in problem behaviors including bullying and hyperactivity/inattention, and also less separation anxiety after the introduction of a shelter cat,” said Gretchen Carlisle, PhD, MEd, RN, research scientist at the University of Missouri Research Center for Human Animal Interaction (ReCHAI). “Previous research has focused on interactions of dogs with children who have ASD, but dogs may not provide the best fit for all children and their families, especially given the hypersensitivities to sound that are common among children with ASD,” Carlisle said. “We hope the results of this study will help encourage more families to consider the possibility of cat ownership and help more shelter cats find loving, deserving homes.”

“For the first time, we have scientific research that shows how beneficial cats can be for families of children with ASD,” said Steven Feldman, President of HABRI, the primary funder of the study. “Selecting a suitable family pet is an important decision. Families with a child with ASD now have more information and more choices, and we hope that this will also help more shelter cats find good homes.”

Findings of the Feline Friends study, led by researchers at the University of Missouri, demonstrated that children with an adopted shelter cat had better empathy and less separation anxiety, as well as fewer problem behaviors exhibited by less externalizing, bullying and hyperactivity/inattention. Children and parents also felt strong bonds with their new cat almost immediately after adoption and despite the responsibilities involved in care for a cat, these bonds did not decrease over time. The researchers conclude that shelter cats may be beneficial for some children with ASD while not necessarily creating a burden for their parents.

Participating families of children were randomized into two groups. Families in one group adopted a shelter cat immediately and were followed for 18 weeks. Other families were in a control group for 18 weeks with no cat and then adopted a shelter cat and were followed for an additional 18 weeks. Surveys were collected every six weeks measuring children’s social skills and anxiety and parent/child bonds with their cat. Shelter cats available for adoption in the study were all required to pass the Feline Temperament Profile with a score of greater than or equal to 20 identifying them as having a calm temperament.

“In the families of children with ASD who adopted temperament-screened shelter cats in this study, parents and children bonded with their new cats. To our knowledge, no studies prior to this have examined the attachment to the cats of children with ASD and their caregivers after adoption. We hope other scientists will further study cat adoption in families of children with ASD, following this important exploratory study,” said Dr. Vicki Thayer, Interim Executive Director of the Winn Feline Foundation.

The Feline Friends Study was funded by HABRI and the Winn Feline Foundation. Read the full paper in the Journal of Pediatric Nursing: https://doi.org/10.1016/j.pedn.2020.11.011

Citation: Carlisle, Gretchen, et al. “Exploratory Study of Cat Adoption in Families of Children with Autism: Impact on Children’s Social Skills and Anxiety.” Journal of Pediatric Nursing, vol. 58, 6 Dec. 2020, pp. 28–35., doi:https://doi.org/10.1016/j.pedn.2020.11.011.

About ReCHAI

ReCHAI, founded in 2005, operates as a dynamic collaboration between the University of Missouri Sinclair School of Nursing and College of Veterinary Medicine with a mission of education and conducting programs and studies about the benefits of human-animal interaction.

About HABRI

HABRI is a not-for-profit organization that maintains the world’s largest online library of human-animal bond research and information; funds innovative research projects to scientifically document the health benefits of companion animals; and informs the public about human-animal bond research and the beneficial role of companion animals in society. For more information, please visit http://www.habri.org.

About Winn Feline Foundation

Winn Feline Foundation is a nonprofit organization established in 1968 that supports studies to improve cat health. Since 1968, the Winn Feline Foundation has funded more than $7.6 million in health research for cats at more than 30 partner institutions worldwide. For further information, go to http://www.winnfelinefoundation.org.

Share article on social media or email: